Immunoglobulin G glycosylation in aging and diseases

Cellular Immunology

Volumn 333, Issue , 2018, Pages 65-79

  Gudelj, Ivan ^a   Lauc, Gordan ^a,b   Pezer, Marija ^a  

^a GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Aging; Biological age; Biomarker; Differential glycosylation; Disease; IgG glycome

Indexed keywords

GLYCAN; IMMUNOGLOBULIN G; N ACETYLGLUCOSAMINE; BIOLOGICAL MARKER; GLYCOSYLATED IGG;

AGE; ALLOIMMUNE DISEASE; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CORE FUCOSYLATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASES; DYSLIPIDEMIA; FUCOSYLATION; GLYCOSYLATION; HUMAN; IMMUNOCOMPETENT CELL; INFECTION; MALIGNANT NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; SIALYLATION; AGING; DISEASE EXACERBATION; IMMUNOLOGY; METABOLISM;

AGING; BIOMARKERS; DISEASE PROGRESSION; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G;

EID: 85051390023     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2018.07.009     Document Type: Article

References (313)

1. Gonzalez-Quintela, A., Alende, R., Gude, F., Campos, J., Rey, J., Meijide, L.M., Fernandez-Merino, C., Vidal, C., Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin. Exp. Immunol. 151 (2008), 42–50.
2. Krapp, S., Mimura, Y., Jefferis, R., Huber, R., Sondermann, P., Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 325 (2003), 979–989.
3. Seeling, M., Bruckner, C., Nimmerjahn, F., Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?. Nat. Rev. Rheumatol. 13 (2017), 621–630.
4. Dunn-Walters, D., Boursier, L., Spencer, J., Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol. Immunol. 37 (2000), 107–113.
5. Zhu, D., McCarthy, H., Ottensmeier, C.H., Johnson, P., Hamblin, T.J., Stevenson, F.K., Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99 (2002), 2562–2568.
6. Zhu, D., Ottensmeier, C.H., Du, M.Q., McCarthy, H., Stevenson, F.K., Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br. J. Haematol. 120 (2003), 217–222.
7. Jefferis, R., Glycosylation of natural and recombinant antibody molecules. Adv. Exp. Med. Biol. 564 (2005), 143–148.
8. Jefferis, R., Glycosylation of recombinant antibody therapeutics. Biotechnol. Progr. 21 (2005), 11–16.
9. Anumula, K.R., Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc. J. Immunol. Methods 382 (2012), 167–176.
10. Arnold, J.N., Wormald, M.R., Sim, R.B., Rudd, P.M., Dwek, R.A., The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25 (2007), 21–50.
11. Pricer, W.E. Jr., Hudgin, R.L., Ashwell, G., Stockert, R.J., Morell, A.G., A membrane receptor protein for asialoglycoproteins. Methods Enzymol. 34 (1974), 688–691.
12. Mimura, Y., Church, S., Ghirlando, R., Ashton, P.R., Dong, S., Goodall, M., Lund, J., Jefferis, R., The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol. 37 (2000), 697–706.
13. Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J., Young, S.P., Goodall, M., Jefferis, R., Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J. Biol. Chem. 276 (2001), 45539–45547.
14. Shields, R.L., Lai, J., Keck, R., O'Connell, L.Y., Hong, K., Meng, Y.G., Weikert, S.H., Presta, L.G., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277 (2002), 26733–26740.
15. Schwab, I., Nimmerjahn, F., Intravenous immunoglobulin therapy: how does IgG modulate the immune system?. Nat. Rev. Immunol. 13 (2013), 176–189.
16. Pincetic, A., Bournazos, S., DiLillo, D.J., Maamary, J., Wang, T.T., Dahan, R., Fiebiger, B.M., Ravetch, J.V., Type I and type II Fc receptors regulate innate and adaptive immunity. Nat. Immunol. 15 (2014), 707–716.
17. Kao, D., Danzer, H., Collin, M., Gross, A., Eichler, J., Stambuk, J., Lauc, G., Lux, A., Nimmerjahn, F., A Monosaccharide residue is sufficient to maintain mouse and human IgG subclass activity and directs IgG effector functions to cellular Fc receptors. Cell Rep. 13 (2015), 2376–2385.
18. Subedi, G.P., Barb, A.W., The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc gamma receptor. MAbs 8 (2016), 1512–1524.
19. Dekkers, G., Treffers, L., Plomp, R., Bentlage, A.E.H., de Boer, M., Koeleman, C.A.M., Lissenberg-Thunnissen, S.N., Visser, R., Brouwer, M., Mok, J.Y., Matlung, H., van den Berg, T.K., van Esch, W.J.E., Kuijpers, T.W., Wouters, D., Rispens, T., Wuhrer, M., Vidarsson, G., Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of fc-receptor- and complement-mediated-effector activities. Front. Immunol., 8, 2017, 877.
20. Bruggeman, C.W., Dekkers, G., Bentlage, A.E.H., Treffers, L.W., Nagelkerke, S.Q., Lissenberg-Thunnissen, S., Koeleman, C.A.M., Wuhrer, M., van den Berg, T.K., Rispens, T., Vidarsson, G., Kuijpers, T.W., Enhanced effector functions due to antibody defucosylation depend on the effector cell fcgamma receptor profile. J. Immunol. 199 (2017), 204–211.
21. Gornik, O., Pavic, T., Lauc, G., Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease. Biochim. Biophys. Acta 2012 (1820), 1318–1326.
22. Wright, A., Tao, M.H., Kabat, E.A., Morrison, S.L., Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J. 10 (1991), 2717–2723.
23. Coloma, M.J., Trinh, R.K., Martinez, A.R., Morrison, S.L., Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1–>6) dextran antibody. J. Immunol. 162 (1999), 2162–2170.
24. Leibiger, H., Wustner, D., Stigler, R.D., Marx, U., Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding. Biochem. J. 338:Pt 2 (1999), 529–538.
25. Holland, M., Yagi, H., Takahashi, N., Kato, K., Savage, C.O., Goodall, D.M., Jefferis, R., Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim. Biophys. Acta 1760 (2006), 669–677.
26. Bondt, A., Rombouts, Y., Selman, M.H., Hensbergen, P.J., Reiding, K.R., Hazes, J.M., Dolhain, R.J., Wuhrer, M., IgG Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol. Cell. Proteomics, 2014.
27. van de Bovenkamp, F.S., Hafkenscheid, L., Rispens, T., Rombouts, Y., The emerging importance of IgG Fab glycosylation in immunity. J. Immunol. 196 (2016), 1435–1441.
28. Rombouts, Y., Willemze, A., van Beers, J.J., Shi, J., Kerkman, P.F., van Toorn, L., Janssen, G.M., Zaldumbide, A., Hoeben, R.C., Pruijn, G.J., Deelder, A.M., Wolbink, G., Rispens, T., van Veelen, P.A., Huizinga, T.W., Wuhrer, M., Trouw, L.A., Scherer, H.U., Toes, R.E., Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Ann. Rheumatic Dis. 75 (2016), 578–585.
29. van de Bovenkamp, F.S., Derksen, N.I.L., Ooijevaar-de Heer, P., van Schie, K.A., Kruithof, S., Berkowska, M.A., van der Schoot, C.E., I.J, H, van der Burg, M., Gils, A., Hafkenscheid, L., Toes, R.E.M., Rombouts, Y., Plomp, R., Wuhrer, M., van Ham, S.M., Vidarsson, G., Rispens, T., Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region. Proc. Natl. Acad. Sci. U.S.A. 115 (2018), 1901–1906.
30. Parekh, R.B., Dwek, R.A., Sutton, B.J., Fernandes, D.L., Leung, A., Stanworth, D., Rademacher, T.W., Mizuochi, T., Taniguchi, T., Matsuta, K., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316 (1985), 452–457.
31. Flogel, M., Lauc, G., Gornik, I., Macek, B., Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis. Clin. Chem. Lab. Med.: CCLM/FESCC 36 (1998), 99–102.
32. Tsuchiya, N., Endo, T., Kochibe, N., Ito, K., Kobata, A., Use of lectin for detection of agalactosyl IgG. Methods Mol. Med. 9 (1998), 195–205.
33. Dalziel, M., McFarlane, I., Axford, J.S., Lectin analysis of human immunoglobulin G N-glycan sialylation. Glycoconjugate J. 16 (1999), 801–807.
34. Ruhaak, L.R., Uh, H.W., Beekman, M., Koeleman, C.A., Hokke, C.H., Westendorp, R.G., Wuhrer, M., Houwing-Duistermaat, J.J., Slagboom, P.E., Deelder, A.M., Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS One, 5, 2010, e12566.
35. Reusch, D., Haberger, M., Kailich, T., Heidenreich, A.K., Kampe, M., Bulau, P., Wuhrer, M., High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzer. MAbs, 6, 2013 published online.
36. Stockmann, H., Adamczyk, B., Hayes, J., Rudd, P.M., Automated, high-throughput IgG-antibody glycoprofiling platform. Anal. Chem. 85 (2013), 8841–8849.
37. Bakovic, M.P., Selman, M.H., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A.M., Lauc, G., Wuhrer, M., High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 12 (2013), 821–831.
38. Huffman, J.E., Pucic-Bakovic, M., Klaric, L., Hennig, R., Selman, M.H., Vuckovic, F., Novokmet, M., Kristic, J., Borowiak, M., Muth, T., Polasek, O., Razdorov, G., Gornik, O., Plomp, R., Theodoratou, E., Wright, A.F., Rudan, I., Hayward, C., Campbell, H., Deelder, A.M., Reichl, U., Aulchenko, Y.S., Rapp, E., Wuhrer, M., Lauc, G., Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol. Cell. Proteomics 13 (2014), 1598–1610.
39. Mahan, A.E., Tedesco, J., Dionne, K., Baruah, K., Cheng, H.D., De Jager, P.L., Barouch, D.H., Suscovich, T., Ackerman, M., Crispin, M., Alter, G., A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J. Immunol. Methods 417 (2015), 34–44.
40. Trbojevic-Akmacic, I., Vilaj, M., Lauc, G., High-throughput analysis of immunoglobulin G glycosylation. Expert Rev. proteomics 13 (2016), 523–534.
41. Jansen, B.C., Bondt, A., Reiding, K.R., Scherjon, S.A., Vidarsson, G., Wuhrer, M., MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns. Sci. Rep., 6, 2016, 34001.
42. Trbojevic-Akmacic, I., Ugrina, I., Lauc, G., Comparative analysis and validation of different steps in glycomics studies. Methods Enzymol. 586 (2017), 37–55.
43. Endo, T., Wright, A., Morrison, S.L., Kobata, A., Glycosylation of the variable region of immunoglobulin G–site specific maturation of the sugar chains. Mol. Immunol. 32 (1995), 931–940.
44. Youings, A., Chang, S.C., Dwek, R.A., Scragg, I.G., Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 314:Pt 2 (1996), 621–630.
45. Wormald, M.R., Rudd, P.M., Harvey, D.J., Chang, S.C., Scragg, I.G., Dwek, R.A., Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36 (1997), 1370–1380.
46. Wuhrer, M., Stam, J.C., van de Geijn, F.E., Koeleman, C.A., Verrips, C.T., Dolhain, R.J., Hokke, C.H., Deelder, A.M., Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 7 (2007), 4070–4081.
47. Mimura, Y., Ashton, P.R., Takahashi, N., Harvey, D.J., Jefferis, R., Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J. Immunol. Methods 326 (2007), 116–126.
48. Stadlmann, J., Pabst, M., Kolarich, D., Kunert, R., Altmann, F., Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 8 (2008), 2858–2871.
49. Selman, M.H., de Jong, S.E., Soonawala, D., Kroon, F.P., Adegnika, A.A., Deelder, A.M., Hokke, C.H., Yazdanbakhsh, M., Wuhrer, M., Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Mol. Cell. Proteomics, 11, 2012, M111 014563.
50. Bohm, S., Schwab, I., Lux, A., Nimmerjahn, F., The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin. Immunopathol. 34 (2012), 443–453.
51. Rombouts, Y., Ewing, E., van de Stadt, L.A., Selman, M.H., Trouw, L.A., Deelder, A.M., Huizinga, T.W., Wuhrer, M., van Schaardenburg, D., Toes, R.E., Scherer, H.U., Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann. Rheumatic Dis., 2013.
52. Plomp, R., Ruhaak, L.R., Uh, H.W., Reiding, K.R., Selman, M., Houwing-Duistermaat, J.J., Slagboom, P.E., Beekman, M., Wuhrer, M., Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. Sci. Rep., 7, 2017, 12325.
53. Hafkenscheid, L., Bondt, A., Scherer, H.U., Huizinga, T.W., Wuhrer, M., Toes, R.E., Rombouts, Y., Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans. Mol. Cell. Proteomics 16 (2017), 278–287.
54. Novak, J., Tomana, M., Shah, G.R., Brown, R., Mestecky, J., Heterogeneity of IgG glycosylation in adult periodontal disease. J. Dent. Res. 84 (2005), 897–901.
55. Stefanovic, G., Markovic, D., Ilic, V., Brajovic, G., Petrovic, S., Milosevic-Jovcic, N., Hypogalactosylation of salivary and gingival fluid immunoglobulin G in patients with advanced periodontitis. J. Periodontol. 77 (2006), 1887–1893.
56. Scherer, H.U., van der Woude, D., Ioan-Facsinay, A., el Bannoudi, H., Trouw, L.A., Wang, J., Haupl, T., Burmester, G.R., Deelder, A.M., Huizinga, T.W., Wuhrer, M., Toes, R.E., Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheumatism 62 (2010), 1620–1629.
57. Kratz, E.M., Ferens-Sieczkowska, M., Faundez, R., Katnik-Prastowska, I., Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients. Glycoconjugate J. 31 (2014), 51–60.
58. Wuhrer, M., Selman, M.H., McDonnell, L.A., Kumpfel, T., Derfuss, T., Khademi, M., Olsson, T., Hohlfeld, R., Meinl, E., Krumbholz, M., Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. J. Neuroinflammation, 12, 2015, 235.
59. Hudetz, D., Boric, I., Rod, E., Jelec, Z., Radic, A., Vrdoljak, T., Skelin, A., Lauc, G., Trbojevic-Akmacic, I., Plecko, M., Polasek, O., Primorac, D., The effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes, 8, 2017.
60. Masuda, K., Yamaguchi, Y., Kato, K., Takahashi, N., Shimada, I., Arata, Y., Pairing of oligosaccharides in the Fc region of immunoglobulin G. FEBS Lett. 473 (2000), 349–357.
61. Pucic, M., Knezevic, A., Vidic, J., Adamczyk, B., Novokmet, M., Polasek, O., Gornik, O., Supraha-Goreta, S., Wormald, M.R., Redzic, I., Campbell, H., Wright, A., Hastie, N.D., Wilson, J.F., Rudan, I., Wuhrer, M., Rudd, P.M., Josic, D., Lauc, G., High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell. Proteomics: MCP, 10, 2011 M111.010090-M010111.010090.
62. Gornik, O., Wagner, J., Pucic, M., Knezevic, A., Redzic, I., Lauc, G., Stability of N-glycan profiles in human plasma. Glycobiology 19 (2009), 1547–1553.
63. Novokmet, M., Lukic, E., Vuckovic, F., Ethuric, Z., Keser, T., Rajsl, K., Remondini, D., Castellani, G., Gasparovic, H., Gornik, O., Lauc, G., Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci. Rep., 4, 2014, 4347.
64. Hennig, R., Cajic, S., Borowiak, M., Hoffmann, M., Kottler, R., Reichl, U., Rapp, E., Towards personalized diagnostics via longitudinal study of the human plasma N-glycome. Biochim. Biophys. Acta 2016 (1860), 1728–1738.
65. Kristic, J., Vuckovic, F., Menni, C., Klaric, L., Keser, T., Beceheli, I., Pucic-Bakovic, M., Novokmet, M., Mangino, M., Thaqi, K., Rudan, P., Novokmet, N., Sarac, J., Missoni, S., Kolcic, I., Polasek, O., Rudan, I., Campbell, H., Hayward, C., Aulchenko, Y., Valdes, A., Wilson, J.F., Gornik, O., Primorac, D., Zoldos, V., Spector, T., Lauc, G., Glycans are a novel biomarker of chronological and biological ages. J. Gerontol. Series A, Biol. Sci. Med. Sci. 69 (2014), 779–789.
66. Parekh, R., Roitt, I., Isenberg, D., Dwek, R., Rademacher, T., Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 167 (1988), 1731–1736.
67. Rook, G.A., Steele, J., Brealey, R., Whyte, A., Isenberg, D., Sumar, N., Nelson, J.L., Bodman, K.B., Young, A., Roitt, I.M., et al. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmunity 4 (1991), 779–794.
68. Yamada, E., Tsukamoto, Y., Sasaki, R., Yagyu, K., Takahashi, N., Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconjugate J. 14 (1997), 401–405.
69. Shikata, K., Yasuda, T., Takeuchi, F., Konishi, T., Nakata, M., Mizuochi, T., Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconjugate journal 15 (1998), 683–689.
70. van de Geijn, F.E., Wuhrer, M., Selman, M.H., Willemsen, S.P., de Man, Y.A., Deelder, A.M., Hazes, J.M., Dolhain, R.J., Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res. Ther., 11, 2009, R193.
71. Engdahl, C., Bondt, A., Harre, U., Raufer, J., Pfeifle, R., Camponeschi, A., Wuhrer, M., Seeling, M., Martensson, I.L., Nimmerjahn, F., Kronke, G., Scherer, H.U., Forsblad-d'Elia, H., Schett, G., Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women. Arthritis Res. Ther., 20, 2018, 84.
72. P. Stanley, H. Schachter, N. Taniguchi, N-Glycans, in: nd, A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.) Essentials of Glycobiology, Cold Spring Harbor (NY), 2009.
73. Lauc, G., Huffman, J.E., Pucic, M., Zgaga, L., Adamczyk, B., Muzinic, A., Novokmet, M., Polasek, O., Gornik, O., Kristic, J., Keser, T., Vitart, V., Scheijen, B., Uh, H.W., Molokhia, M., Patrick, A.L., McKeigue, P., Kolcic, I., Lukic, I.K., Swann, O., van Leeuwen, F.N., Ruhaak, L.R., Houwing-Duistermaat, J.J., Slagboom, P.E., Beekman, M., de Craen, A.J., Deelder, A.M., Zeng, Q., Wang, W., Hastie, N.D., Gyllensten, U., Wilson, J.F., Wuhrer, M., Wright, A.F., Rudd, P.M., Hayward, C., Aulchenko, Y., Campbell, H., Rudan, I., Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet., 9, 2013, e1003225.
74. Menni, C., Keser, T., Mangino, M., Bell, J.T., Erte, I., Akmačić I., Vučković F., Pučić-Baković M., Gornik, O., McCarthy, M.I., Zoldoš V., Spector, T.D., Lauc, G., Valdes, A., Glycosylation of Immunoglobulin G: role of genetic and epigenetic influences. PLoS One, 8, 2013, e82558.
75. Wahl, A., Kasela, S., Monotoro, E.C., van Iterson, M., Stambuk, J., Sharma, S., van den Akker, E., Klaric, L., Benedetti, E., Razdorov, G., Trbojevic-Akmacic, I., Vuckovic, F., Ugrina, I., Beekman, M., Deelen, J., van Heemst, D., Heijmans, B.T., Consortium, B., Wuhrer, M., Plomp, R., Keser, T., Simurina, M., Pavic, T., Gudelj, I., Kristic, J., Grallert, H., Kunze, S., Peters, A., Bell, J.T., Spector, T.D., Milani, L., Eline Slagboom, P., Lauc, G., Gieger, C., IgG glycosylation and DNA methylation are interconnected with smoking. Biochim. Biophys. Acta, 2017.
76. Wahl, A., van den Akker, E., Klaric, L., Stambuk, J., Benedetti, E., Plomp, R., Razdorov, G., Trbojevic-Akmacic, I., Deelen, J., van Heemst, D., Slagboom, P.E., Vuckovic, F., Grallert, H., Krumsiek, J., Strauch, K., Peters, A., Meitinger, T., Hayward, C., Wuhrer, M., Beekman, M., Lauc, G., Gieger, C., Genome-wide association study on immunoglobulin G glycosylation patterns. Front. Immunol., 9, 2018, 277.
77. Huhn, C., Selman, M.H., Ruhaak, L.R., Deelder, A.M., Wuhrer, M., IgG glycosylation analysis. Proteomics 9 (2009), 882–913.
78. Selman, M.H., Derks, R.J., Bondt, A., Palmblad, M., Schoenmaker, B., Koeleman, C.A., van de Geijn, F.E., Dolhain, R.J., Deelder, A.M., Wuhrer, M., Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J. Proteomics 75 (2012), 1318–1329.
79. Bondt, A., Selman, M.H., Deelder, A.M., Hazes, J.M., Willemsen, S.P., Wuhrer, M., Dolhain, R.J., Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J. Proteome Res. 12 (2013), 4522–4531.
80. Ercan, A., Kohrt, W.M., Cui, J., Deane, K.D., Pezer, M., Yu, E.W., Hausmann, J.S., Campbell, H., Kaiser, U.B., Rudd, P.M., Lauc, G., Wilson, J.F., Finkelstein, J.S., Nigrovic, P.A., Estrogens regulate glycosylation of IgG in women and men. JCI Insight, 2, 2017, e89703.
81. Dube, R., Rook, G.A., Steele, J., Brealey, R., Dwek, R., Rademacher, T., Lennard-Jones, J., Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 31 (1990), 431–434.
82. Troelsen, L.N., Jacobsen, S., Abrahams, J.L., Royle, L., Rudd, P.M., Narvestad, E., Heegaard, N.H., Garred, P., IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis. J. Rheumatol. 39 (2012), 463–469.
83. Nikolac Perkovic, M., Pucic Bakovic, M., Kristic, J., Novokmet, M., Huffman, J.E., Vitart, V., Hayward, C., Rudan, I., Wilson, J.F., Campbell, H., Polasek, O., Lauc, G., Pivac, N., The association between galactosylation of immunoglobulin G and body mass index. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48 (2014), 20–25.
84. Barrios, C., Zierer, J., Gudelj, I., Stambuk, J., Ugrina, I., Rodriguez, E., Soler, M.J., Pavic, T., Simurina, M., Keser, T., Pucic-Bakovic, M., Mangino, M., Pascual, J., Spector, T.D., Lauc, G., Menni, C., Glycosylation profile of IgG in moderate kidney dysfunction. J. Am. Soc. Nephrol.: JASN 27 (2016), 933–941.
85. Wang, Y., Klaric, L., Yu, X., Thaqi, K., Dong, J., Novokmet, M., Wilson, J., Polasek, O., Liu, Y., Kristic, J., Ge, S., Pucic-Bakovic, M., Wu, L., Zhou, Y., Ugrina, I., Song, M., Zhang, J., Guo, X., Zeng, Q., Rudan, I., Campbell, H., Aulchenko, Y., Lauc, G., Wang, W., The association between glycosylation of immunoglobulin G and hypertension: a multiple ethnic cross-sectional study. Medicine, 95, 2016, e3379.
86. de Jong, S.E., Selman, M.H., Adegnika, A.A., Amoah, A.S., van Riet, E., Kruize, Y.C., Raynes, J.G., Rodriguez, A., Boakye, D., von Mutius, E., Knulst, A.C., Genuneit, J., Cooper, P.J., Hokke, C.H., Wuhrer, M., Yazdanbakhsh, M., IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci. Rep., 6, 2016, 28207.
87. Pezer, M., Stambuk, J., Perica, M., Razdorov, G., Banic, I., Vuckovic, F., Gospic, A.M., Ugrina, I., Vecenaj, A., Bakovic, M.P., Lokas, S.B., Zivkovic, J., Plavec, D., Devereux, G., Turkalj, M., Lauc, G., Effects of allergic diseases and age on the composition of serum IgG glycome in children. Sci. Rep., 6, 2016, 33198.
88. Gao, Q., Dolikun, M., Stambuk, J., Wang, H., Zhao, F., Yiliham, N., Wang, Y., Trbojevic-Akmacic, I., Zhang, J., Fang, H., Sun, Y., Peng, H., Zhao, Z., Liu, D., Liu, J., Li, Q., Sun, Q., Wu, L., Lauc, G., Wang, W., Song, M., Immunoglobulin G N-glycans as potential postgenomic biomarkers for hypertension in the kazakh population. OMICS: J. Integr. Biol. 21 (2017), 380–389.
89. Keser, T., Vuckovic, F., Barrios, C., Zierer, J., Wahl, A., Akinkuolie, A.O., Stambuk, J., Nakic, N., Pavic, T., Perisa, J., Mora, S., Gieger, C., Menni, C., Spector, T.D., Gornik, O., Lauc, G., Effects of statins on the immunoglobulin G glycome. Biochim. Biophys. Acta 2017 (1861), 1152–1158.
90. Menni, C., Gudelj, I., Macdonald-Dunlop, E., Mangino, M., Zierer, J., Besic, E., Joshi, P.K., Trbojevic-Akmacic, I., Chowienczyk, P.J., Spector, T.D., Wilson, J.F., Lauc, G., Valdes, A.M., Glycosylation profile of immunoglobulin G is cross-sectionally associated with cardiovascular disease risk score and subclinical atherosclerosis in two independent cohorts. Circ. Res. 122 (2018), 1555–1564.
91. Banda, N.K., Wood, A.K., Takahashi, K., Levitt, B., Rudd, P.M., Royle, L., Abrahams, J.L., Stahl, G.L., Holers, V.M., Arend, W.P., Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheumatism 58 (2008), 3081–3089.
92. Malhotra, R., Wormald, M.R., Rudd, P.M., Fischer, P.B., Dwek, R.A., Sim, R.B., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1 (1995), 237–243.
93. Ji, H., Ohmura, K., Mahmood, U., Lee, D.M., Hofhuis, F.M., Boackle, S.A., Takahashi, K., Holers, V.M., Walport, M., Gerard, C., Ezekowitz, A., Carroll, M.C., Brenner, M., Weissleder, R., Verbeek, J.S., Duchatelle, V., Degott, C., Benoist, C., Mathis, D., Arthritis critically dependent on innate immune system players. Immunity 16 (2002), 157–168.
94. Arnold, J.N., Dwek, R.A., Rudd, P.M., Sim, R.B., Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol. Lett. 106 (2006), 103–110.
95. Nimmerjahn, F., Anthony, R.M., Ravetch, J.V., Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. PNAS 104 (2007), 8433–8437.
96. van de Geijn, F.E., Hazes, J.M., Geleijns, K., Emonts, M., Jacobs, B.C., Dufour-van den Goorbergh, B.C., Dolhain, R.J., Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis–confirmation in two large cohorts. Rheumatology 47 (2008), 1168–1171.
97. van de Geijn, F.E., de Man, Y.A., Wuhrer, M., Willemsen, S.P., Deelder, A.M., Hazes, J.M., Dolhain, R.J., Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis. Arthritis Res. Ther., 13, 2011, R10.
98. Karsten, C.M., Pandey, M.K., Figge, J., Kilchenstein, R., Taylor, P.R., Rosas, M., McDonald, J.U., Orr, S.J., Berger, M., Petzold, D., Blanchard, V., Winkler, A., Hess, C., Reid, D.M., Majoul, I.V., Strait, R.T., Harris, N.L., Kohl, G., Wex, E., Ludwig, R., Zillikens, D., Nimmerjahn, F., Finkelman, F.D., Brown, G.D., Ehlers, M., Kohl, J., Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fcgamma RIIB and dectin-1. Nat. Med. 18 (2012), 1401–1406.
99. Mihai, S., Nimmerjahn, F., The role of Fc receptors and complement in autoimmunity. Autoimmun. Rev., 2012.
100. Boyd, P.N., Lines, A.C., Patel, A.K., The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol. Immunol. 32 (1995), 1311–1318.
101. Hodoniczky, J., Zheng, Y.Z., James, D.C., Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol. Prog. 21 (2005), 1644–1652.
102. Peschke, B., Keller, C.W., Weber, P., Quast, I., Lunemann, J.D., Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity. Front. Immunol., 8, 2017, 646.
103. Kumpel, B.M., Rademacher, T.W., Rook, G.A., Williams, P.J., Wilson, I.B., Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum. Antibodies Hybridomas 5 (1994), 143–151.
104. Kumpel, B.M., Wang, Y., Griffiths, H.L., Hadley, A.G., Rook, G.A., The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. Hum. Antibodies Hybridomas 6 (1995), 82–88.
105. Houde, D., Peng, Y., Berkowitz, S.A., Engen, J.R., Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol. Cell. Proteomics 9 (2010), 1716–1728.
106. Kaneko, Y., Nimmerjahn, F., Ravetch, J.V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313 (2006), 670–673.
107. Anthony, R.M., Nimmerjahn, F., Ashline, D.J., Reinhold, V.N., Paulson, J.C., Ravetch, J.V., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320 (2008), 373–376.
108. Nimmerjahn, F., Ravetch, J.V., Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 26 (2008), 513–533.
109. Schwab, I., Biburger, M., Kronke, G., Schett, G., Nimmerjahn, F., IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1. Eur. J. Immunol. 42 (2012), 826–830.
110. Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J.C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., Garofalo, K., Meccariello, R., Meador, J.W. 3rd, Rutitzky, L., Schultes, B.C., Ling, L., Avery, W., Nimmerjahn, F., Manning, A.M., Kaundinya, G.V., Bosques, C.J., Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. Proc. Natl. Acad. Sci. U.S.A., 2015.
111. Guhr, T., Bloem, J., Derksen, N.I., Wuhrer, M., Koenderman, A.H., Aalberse, R.C., Rispens, T., Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS One, 6, 2011, e21246.
112. Leontyev, D., Katsman, Y., Ma, X.Z., Miescher, S., Kasermann, F., Branch, D.R., Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin. Transfusion 52 (2012), 1799–1805.
113. Campbell, I.K., Miescher, S., Branch, D.R., Mott, P.J., Lazarus, A.H., Han, D., Maraskovsky, E., Zuercher, A.W., Neschadim, A., Leontyev, D., McKenzie, B.S., Kasermann, F., Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J. Immunol. 192 (2014), 5031–5038.
114. Epp, A., Hobusch, J., Bartsch, Y.C., Petry, J., Lilienthal, G.M., Koeleman, C.A.M., Eschweiler, S., Mobs, C., Hall, A., Morris, S.C., Braumann, D., Engellenner, C., Bitterling, J., Rahmoller, J., Leliavski, A., Thurmann, R., Collin, M., Moremen, K.W., Strait, R.T., Blanchard, V., Petersen, A., Gemoll, T., Habermann, J.K., Petersen, F., Nandy, A., Kahlert, H., Hertl, M., Wuhrer, M., Pfutzner, W., Jappe, U., Finkelman, F.D., Ehlers, M., Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions. J. Allergy Clin. Immunol. 141 (2018), 399–402 e398.
115. A. Winkler, M. Berger, M. Ehlers. Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies 2 F1000Research, 2013, 169.
116. Ogata, S., Shimizu, C., Franco, A., Touma, R., Kanegaye, J.T., Choudhury, B.P., Naidu, N.N., Kanda, Y., Hoang, L.T., Hibberd, M.L., Tremoulet, A.H., Varki, A., Burns, J.C., Treatment response in kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin g. PLoS One, 8, 2013, e81448.
117. Scallon, B.J., Tam, S.H., McCarthy, S.G., Cai, A.N., Raju, T.S., Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol. Immunol. 44 (2007), 1524–1534.
118. Raju, T.S., Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr. Opin. Immunol. 20 (2008), 471–478.
119. Maverakis, E., Kim, K., Shimoda, M., Gershwin, M.E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L.R., Lebrilla, C.B., Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J. Autoimmun. 57 (2015), 1–13.
120. Yu, X., Baruah, K., Harvey, D.J., Vasiljevic, S., Alonzi, D.S., Song, B.D., Higgins, M.K., Bowden, T.A., Scanlan, C.N., Crispin, M., Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies. J. Am. Chem. Soc. 135 (2013), 9723–9732.
121. Oefner, C.M., Winkler, A., Hess, C., Lorenz, A.K., Holecska, V., Huxdorf, M., Schommartz, T., Petzold, D., Bitterling, J., Schoen, A.L., Stoehr, A.D., Vu Van, D., Darcan-Nikolaisen, Y., Blanchard, V., Schmudde, I., Laumonnier, Y., Strover, H.A., Hegazy, A.N., Eiglmeier, S., Schoen, C.T., Mertes, M.M., Loddenkemper, C., Lohning, M., Konig, P., Petersen, A., Luger, E.O., Collin, M., Kohl, J., Hutloff, A., Hamelmann, E., Berger, M., Wardemann, H., Ehlers, M., Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J. Allergy Clin. Immunol. 129 (2012), 1647–1655 e1613.
122. Hess, C., Winkler, A., Lorenz, A.K., Holecska, V., Blanchard, V., Eiglmeier, S., Schoen, A.L., Bitterling, J., Stoehr, A.D., Petzold, D., Schommartz, T., Mertes, M.M., Schoen, C.T., Tiburzy, B., Herrmann, A., Kohl, J., Manz, R.A., Madaio, M.P., Berger, M., Wardemann, H., Ehlers, M., T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 123 (2013), 3788–3796.
123. Samuelsson, A., Towers, T.L., Ravetch, J.V., Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291 (2001), 484–486.
124. Hibbert, R.G., Teriete, P., Grundy, G.J., Beavil, R.L., Reljic, R., Holers, V.M., Hannan, J.P., Sutton, B.J., Gould, H.J., McDonnell, J.M., The structure of human CD23 and its interactions with IgE and CD21. J. Exp. Med. 202 (2005), 751–760.
125. Anthony, R.M., Wermeling, F., Karlsson, M.C., Ravetch, J.V., Identification of a receptor required for the anti-inflammatory activity of IVIG. PNAS 105 (2008), 19571–19578.
126. Yabe, R., Tateno, H., Hirabayashi, J., Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans. FEBS J. 277 (2010), 4010–4026.
127. Blank, M., Shoenfeld, Y., Sialic acid-IVIg targeting CD22. Blood 116 (2010), 1630–1632.
128. Acharya, M., Borland, G., Edkins, A.L., Maclellan, L.M., Matheson, J., Ozanne, B.W., Cushley, W., CD23/FcepsilonRII: molecular multi-tasking. Clin. Exp. Immunol. 162 (2010), 12–23.
129. Anthony, R.M., Kobayashi, T., Wermeling, F., Ravetch, J.V., Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 475 (2011), 110–113.
130. Yu, X., Vasiljevic, S., Mitchell, D.A., Crispin, M., Scanlan, C.N., Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. J. Mol. Biol. 425 (2013), 1253–1258.
131. Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., Ravetch, J.V., General mechanism for modulating immunoglobulin effector function. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 9868–9872.
132. Collin, M., Ehlers, M., The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies. Exp. Dermatol. 22 (2013), 511–514.
133. Crispin, M., Yu, X., Bowden, T.A., Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), E3544–3546.
134. Nagelkerke, S.Q., Dekkers, G., Kustiawan, I., van de Bovenkamp, F.S., Geissler, J., Plomp, R., Wuhrer, M., Vidarsson, G., Rispens, T., van den Berg, T.K., Kuijpers, T.W., Inhibition of FcgammaR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcgammaRIIb in human macrophages. Blood 124 (2014), 3709–3718.
135. Quast, I., Keller, C.W., Maurer, M.A., Giddens, J.P., Tackenberg, B., Wang, L.X., Munz, C., Nimmerjahn, F., Dalakas, M.C., Lunemann, J.D., Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J. Clin. Invest. 125 (2015), 4160–4170.
136. Jones, M.B., Nasirikenari, M., Lugade, A.A., Thanavala, Y., Lau, J.T., Anti-inflammatory IgG production requires functional P1 promoter in beta-galactoside alpha2,6-sialyltransferase 1 (ST6Gal-1) gene. J. Biol. Chem. 287 (2012), 15365–15370.
137. Jones, M.B., Oswald, D.M., Joshi, S., Whiteheart, S.W., Orlando, R., Cobb, B.A., B-cell-independent sialylation of IgG. Proc. Natl. Acad. Sci. U.S.A. 113 (2016), 7207–7212.
138. Pagan, J.D., Kitaoka, M., Anthony, R.M., Engineered sialylation of pathogenic antibodies in vivo attenuates autoimmune disease. Cell 172 (2018), 564–577 e513.
139. Knežević A., Polašek, O., Gornik, O., Rudan, I., Campbell, H., Hayward, C., Wright, A., Kolčić I., O'Donoghue, N., Bones, J., Rudd, P.M., Lauc, G., Variability, heritability and environmental determinants of human plasma N-Glycome. J. Proteome Res. 8 (2009), 694–701.
140. Kobata, A., The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles. Biochim. Biophys. Acta 1780 (2008), 472–478.
141. Zauner, G., Selman, M.H., Bondt, A., Rombouts, Y., Blank, D., Deelder, A.M., Wuhrer, M., Glycoproteomic analysis of antibodies. Mol. Cell. Proteomics 12 (2013), 856–865.
142. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., Hanai, N., Shitara, K., The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278 (2003), 3466–3473.
143. Niwa, R., Hatanaka, S., Shoji-Hosaka, E., Sakurada, M., Kobayashi, Y., Uehara, A., Yokoi, H., Nakamura, K., Shitara, K., Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism. Clin. Cancer Res. 10 (2004), 6248–6255.
144. Iida, S., Misaka, H., Inoue, M., Shibata, M., Nakano, R., Yamane-Ohnuki, N., Wakitani, M., Yano, K., Shitara, K., Satoh, M., Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa. Clin. Cancer Res. 12 (2006), 2879–2887.
145. Ferrara, C., Stuart, F., Sondermann, P., Brunker, P., Umana, P., The carbohydrate at FcgammaRIIIa Asn-162 An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 281 (2006), 5032–5036.
146. Preithner, S., Elm, S., Lippold, S., Locher, M., Wolf, A., da Silva, A.J., Baeuerle, P.A., Prang, N.S., High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G. Mol. Immunol. 43 (2006), 1183–1193.
147. Matsumiya, S., Yamaguchi, Y., Saito, J., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., Kato, K., Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J. Mol. Biol. 368 (2007), 767–779.
148. Masuda, K., Kubota, T., Kaneko, E., Iida, S., Wakitani, M., Kobayashi-Natsume, Y., Kubota, A., Shitara, K., Nakamura, K., Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol. Immunol. 44 (2007), 3122–3131.
149. Kanda, Y., Yamada, T., Mori, K., Okazaki, A., Inoue, M., Kitajima-Miyama, K., Kuni-Kamochi, R., Nakano, R., Yano, K., Kakita, S., Shitara, K., Satoh, M., Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology 17 (2007), 104–118.
150. Dekkers, G., Bentlage, A.E.H., Plomp, R., Visser, R., Koeleman, C.A.M., Beentjes, A., Mok, J.Y., van Esch, W.J.E., Wuhrer, M., Rispens, T., Vidarsson, G., Conserved FcgammaR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice. Mol. Immunol. 94 (2017), 54–60.
151. Scanlan, C.N., Burton, D.R., Dwek, R.A., Making autoantibodies safe. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 4081–4082.
152. Schuster, M., Umana, P., Ferrara, C., Brunker, P., Gerdes, C., Waxenecker, G., Wiederkum, S., Schwager, C., Loibner, H., Himmler, G., Mudde, G.C., Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering. Cancer Res. 65 (2005), 7934–7941.
153. Benedetti, E., Pucic-Bakovic, M., Keser, T., Wahl, A., Hassinen, A., Yang, J.Y., Liu, L., Trbojevic-Akmacic, I., Razdorov, G., Stambuk, J., Klaric, L., Ugrina, I., Selman, M.H.J., Wuhrer, M., Rudan, I., Polasek, O., Hayward, C., Grallert, H., Strauch, K., Peters, A., Meitinger, T., Gieger, C., Vilaj, M., Boons, G.J., Moremen, K.W., Ovchinnikova, T., Bovin, N., Kellokumpu, S., Theis, F.J., Lauc, G., Krumsiek, J., Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway. Nat. Commun., 8, 2017, 1483.
154. Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H., Bailey, J.E., Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. 17 (1999), 176–180.
155. Davies, J., Jiang, L., Pan, L.Z., LaBarre, M.J., Anderson, D., Reff, M., Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol. Bioeng. 74 (2001), 288–294.
156. de Haan, N., Reiding, K.R., Driessen, G., van der Burg, M., Wuhrer, M., Changes in healthy human IgG Fc-glycosylation after birth and during early childhood. J. Proteome Res. 15 (2016), 1853–1861.
157. Pucic, M., Muzinic, A., Novokmet, M., Skledar, M., Pivac, N., Lauc, G., Gornik, O., Changes in plasma and IgG N-glycome during childhood and adolescence. Glycobiology 22 (2012), 975–982.
158. Vanhooren, V., Desmyter, L., Liu, X.E., Cardelli, M., Franceschi, C., Federico, A., Libert, C., Laroy, W., Dewaele, S., Contreras, R., Chen, C., N-glycomic changes in serum proteins during human aging. Rejuvenation Res. 10 (2007), 521–531a.
159. Yu, X., Wang, Y., Kristic, J., Dong, J., Chu, X., Ge, S., Wang, H., Fang, H., Gao, Q., Liu, D., Zhao, Z., Peng, H., Pucic Bakovic, M., Wu, L., Song, M., Rudan, I., Campbell, H., Lauc, G., Wang, W., Profiling IgG N-glycans as potential biomarker of chronological and biological ages: a community-based study in a Han Chinese population. Medicine, 95, 2016, e4112.
160. Catera, M., Borelli, V., Malagolini, N., Chiricolo, M., Venturi, G., Reis, C.A., Osorio, H., Abruzzo, P.M., Capri, M., Monti, D., Ostan, R., Franceschi, C., Dall'Olio, F., Identification of novel plasma glycosylation-associated markers of aging. Oncotarget 7 (2016), 7455–7468.
161. Gudelj, I., Keser, T., Vuckovic, F., Skaro, V., Goreta, S.S., Pavic, T., Dumic, J., Primorac, D., Lauc, G., Gornik, O., Estimation of human age using N-glycan profiles from bloodstains. Int. J. Legal Med. 129 (2015), 955–961.
162. Lemmers, R.F.H., Vilaj, M., Urda, D., Agakov, F., Simurina, M., Klaric, L., Rudan, I., Campbell, H., Hayward, C., Wilson, J.F., Lieverse, A.G., Gornik, O., Sijbrands, E.J.G., Lauc, G., van Hoek, M., IgG glycan patterns are associated with type 2 diabetes in independent European populations. Biochim. Biophys. Acta 2017 (1861), 2240–2249.
163. Gudelj, I., Lauc, G., Protein N-glycosylation in cardiovascular diseases and related risk factors. Curr. Cardiovasc. Risk Rep., 12, 2018.
164. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., De Benedictis, G., Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 908 (2000), 244–254.
165. De Martinis, M., Franceschi, C., Monti, D., Ginaldi, L., Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 579 (2005), 2035–2039.
166. Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M.P., Invidia, L., Celani, L., Scurti, M., Cevenini, E., Castellani, G.C., Salvioli, S., Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007), 92–105.
167. Dall'olio, F., Vanhooren, V., Chen, C.C., Slagboom, P.E., Wuhrer, M., Franceschi, C., N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res. Rev., 2012.
168. Muezzinler, A., Zaineddin, A.K., Brenner, H., A systematic review of leukocyte telomere length and age in adults. Ageing Res. Rev. 12 (2013), 509–519.
169. Arai, Y., Martin-Ruiz, C.M., Takayama, M., Abe, Y., Takebayashi, T., Koyasu, S., Suematsu, M., Hirose, N., von Zglinicki, T., Inflammation but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine 2 (2015), 1549–1558.
170. Ruhaak, L.R., Uh, H.W., Beekman, M., Hokke, C.H., Westendorp, R.G., Houwing-Duistermaat, J., Wuhrer, M., Deelder, A.M., Slagboom, P.E., Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. J. Proteome Res. 10 (2011), 1667–1674.
171. Capri, M., Olivieri, F., Lanzarini, C., Remondini, D., Borelli, V., Lazzarini, R., Graciotti, L., Albertini, M.C., Bellavista, E., Santoro, A., Biondi, F., Tagliafico, E., Tenedini, E., Morsiani, C., Pizza, G., Vasuri, F., D'Errico, A., Dazzi, A., Pellegrini, S., Magenta, A., D'Agostino, M., Capogrossi, M.C., Cescon, M., Rippo, M.R., Procopio, A.D., Franceschi, C., Grazi, G.L., Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants. Aging Cell 16 (2017), 262–272.
172. Tomana, M., Schrohenloher, R.E., Koopman, W.J., Alarcon, G.S., Paul, W.A., Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheumatism 31 (1988), 333–338.
173. Parekh, R.B., Roitt, I.M., Isenberg, D.A., Dwek, R.A., Ansell, B.M., Rademacher, T.W., Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1 (1988), 966–969.
174. Young, A., Sumar, N., Bodman, K., Goyal, S., Sinclair, H., Roitt, I., Isenberg, D., Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheumatism 34 (1991), 1425–1429.
175. Axford, J.S., Sumar, N., Alavi, A., Isenberg, D.A., Young, A., Bodman, K.B., Roitt, I.M., Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J. Clin. Invest. 89 (1992), 1021–1031.
176. Bodman, K.B., Sumar, N., Mackenzie, L.E., Isenberg, D.A., Hay, F.C., Roitt, I.M., Lydyard, P.M., Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro. Clin. Exp. Immunol. 88 (1992), 420–423.
177. van Zeben, D., Hazes, J.M., Zwinderman, A.H., Vandenbroucke, J.P., Breedveld, F.C., The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. J. Rheumatol. 21 (1994), 1620–1625.
178. van Zeben, D., Rook, G.A., Hazes, J.M., Zwinderman, A.H., Zhang, Y., Ghelani, S., Rademacher, T.W., Breedveld, F.C., Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br. J. Rheumatol. 33 (1994), 36–43.
179. Tomana, M., Schrohenloher, R.E., Bennett, P.H., del Puente, A., Koopman, W.J., Occurence of deficient galactosylation of serum IgG prior to onset of rheumatoid arthritis. Rheumatol. Int. 13 (1994), 217–220.
180. Bodman-Smith, K., Sumar, N., Sinclair, H., Roitt, I., Isenberg, D., Young, A., Agalactosyl IgG [Gal(o)]–an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis. Br. J. Rheumatol. 35 (1996), 1063–1066.
181. Kuroda, Y., Nakata, M., Makino, A., Matsumoto, A., Ohashi, K., Itahashi, K., Takeuchi, F., Goto, M., Kojima, N., Mizuochi, T., Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome. Glycoconjugate J. 19 (2002), 23–31.
182. Pasek, M., Duk, M., Podbielska, M., Sokolik, R., Szechinski, J., Lisowska, E., Krotkiewski, H., Galactosylation of IgG from rheumatoid arthritis (RA) patients–changes during therapy. Glycoconjugate J. 23 (2006), 463–471.
183. Gindzienska-Sieskiewicz, E., Klimiuk, P.A., Kisiel, D.G., Gindzienski, A., Sierakowski, S., The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis. Clin. Rheumatol. 26 (2007), 685–690.
184. Troelsen, L.N., Garred, P., Madsen, H.O., Jacobsen, S., Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheumatism 56 (2007), 21–29.
185. Croce, A., Firuzi, O., Altieri, F., Eufemi, M., Agostino, R., Priori, R., Bombardieri, M., Alessandri, C., Valesini, G., Saso, L., Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis. J. Clin. Lab. Anal. 21 (2007), 303–314.
186. Ercan, A., Cui, J., Chatterton, D.E., Deane, K.D., Hazen, M.M., Brintnell, W., O'Donnell, C.I., Derber, L.A., Weinblatt, M.E., Shadick, N.A., Bell, D.A., Cairns, E., Solomon, D.H., Holers, V.M., Rudd, P.M., Lee, D.M., Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheumatism 62 (2010), 2239–2248.
187. Saldova, R., Huffman, J.E., Adamczyk, B., Muzinic, A., Kattla, J.J., Pucic, M., Novokmet, M., Abrahams, J.L., Hayward, C., Rudan, I., Wild, S.H., Wright, A.F., Polasek, O., Lauc, G., Campbell, H., Wilson, J.F., Rudd, P.M., Association of medication with the human plasma N-glycome. J. Proteome Res. 11 (2012), 1821–1831.
188. Albrecht, S., Unwin, L., Muniyappa, M., Rudd, P.M., Glycosylation as a marker for inflammatory arthritis. Cancer Biomark.: Section A Dis. Mark. 14 (2014), 17–28.
189. Gindzienska-Sieskiewicz, E., Radziejewska, I., Domyslawska, I., Klimiuk, P.A., Sulik, A., Rojewska, J., Gabryel-Porowska, H., Sierakowski, S., Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate. Adv. Med. Sci. 61 (2016), 193–197.
190. Lundstrom, S.L., Hensvold, A.H., Rutishauser, D., Klareskog, L., Ytterberg, A.J., Zubarev, R.A., Catrina, A.I., IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis. Arthritis Res. Ther., 19, 2017, 182.
191. Gudelj, I., Salo, P.P., Trbojevic-Akmacic, I., Albers, M., Primorac, D., Perola, M., Lauc, G., Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10years of follow-up. Biochim. Biophys. Acta 2018 (1864), 2034–2039.
192. Pekelharing, J.M., Hepp, E., Kamerling, J.P., Gerwig, G.J., Leijnse, B., Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women. Ann. Rheumatic Dis. 47 (1988), 91–95.
193. Tomana, M., Schrohenloher, R.E., Reveille, J.D., Arnett, F.C., Koopman, W.J., Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases. Rheumatol. Int. 12 (1992), 191–194.
194. Go, M.F., Schrohenloher, R.E., Tomana, M., Deficient galactosylation of serum IgG in inflammatory bowel disease: correlation with disease activity. J. Clin. Gastroenterol. 18 (1994), 86–87.
195. Shinzaki, S., Iijima, H., Nakagawa, T., Egawa, S., Nakajima, S., Ishii, S., Irie, T., Kakiuchi, Y., Nishida, T., Yasumaru, M., Kanto, T., Tsujii, M., Tsuji, S., Mizushima, T., Yoshihara, H., Kondo, A., Miyoshi, E., Hayashi, N., IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am. J. Gastroenterol. 103 (2008), 1173–1181.
196. Espy, C., Morelle, W., Kavian, N., Grange, P., Goulvestre, C., Viallon, V., Chereau, C., Pagnoux, C., Michalski, J.C., Guillevin, L., Weill, B., Batteux, F., Guilpain, P., Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). Arthritis Rheumatism 63 (2011), 2105–2115.
197. Nakajima, S., Iijima, H., Shinzaki, S., Egawa, S., Inoue, T., Mukai, A., Hayashi, Y., Kondo, J., Akasaka, T., Nishida, T., Kanto, T., Morii, E., Mizushima, T., Miyoshi, E., Tsujii, M., Hayashi, N., Functional analysis of agalactosyl IgG in inflammatory bowel disease patients. Inflammatory Bowel Dis. 17 (2011), 927–936.
198. Fokkink, W.J., Selman, M.H., Dortland, J.R., Durmus, B., Kuitwaard, K., Huizinga, R., van Rijs, W., Tio-Gillen, A.P., van Doorn, P.A., Deelder, A.M., Wuhrer, M., Jacobs, B.C., IgG Fc N-glycosylation in Guillain-Barre syndrome treated with immunoglobulins. J. Proteome Res. 13 (2014), 1722–1730.
199. Vuckovic, F., Kristic, J., Gudelj, I., Teruel, M., Keser, T., Pezer, M., Pucic-Bakovic, M., Stambuk, J., Trbojevic-Akmacic, I., Barrios, C., Pavic, T., Menni, C., Wang, Y., Zhou, Y., Cui, L., Song, H., Zeng, Q., Guo, X., Pons-Estel, B.A., McKeigue, P., Leslie Patrick, A., Gornik, O., Spector, T.D., Harjacek, M., Alarcon-Riquelme, M., Molokhia, M., Wang, W., Lauc, G., Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol. 67 (2015), 2978–2989.
200. Trbojevic Akmacic, I., Ventham, N.T., Theodoratou, E., Vuckovic, F., Kennedy, N.A., Kristic, J., Nimmo, E.R., Kalla, R., Drummond, H., Stambuk, J., Dunlop, M.G., Novokmet, M., Aulchenko, Y., Gornik, O., Campbell, H., Pucic Bakovic, M., Satsangi, J., Lauc, G., Consortium, I.-B., Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflammatory Bowel Dis. 21 (2015), 1237–1247.
201. Kemna, M.J., Plomp, R., van Paassen, P., Koeleman, C.A.M., Jansen, B.C., Damoiseaux, J., Cohen Tervaert, J.W., Wuhrer, M., Galactosylation and sialylation levels of IgG predict relapse in patients with PR3-ANCA associated vasculitis. EBioMedicine 17 (2017), 108–118.
202. Parekh, R., Isenberg, D., Rook, G., Roitt, I., Dwek, R., Rademacher, T., A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J. Autoimmun. 2 (1989), 101–114.
203. Chou, C.T., Binding of rheumatoid and lupus synovial fluids and sera-derived human IgG rheumatoid factor to degalactosylated IgG. Arch. Med. Res. 33 (2002), 541–544.
204. Canellada, A., Margni, R.A., Modified immunoglobulin G glycosylation pattern during turpentine-induced acute inflammation in rats. Medicina (B Aires) 62 (2002), 249–255.
205. Fratric, N., Gvozdic, D., Vukovic, D., Savic, O., Buac, M., Ilic, V., Evidence that calf bronchopneumonia may be accompanied by increased sialylation of circulating immune complexes’ IgG. Vet. Immunol. Immunopathol. 150 (2012), 161–168.
206. Nimmerjahn, F., Ravetch, J.V., Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8 (2008), 34–47.
207. Matsumoto, A., Shikata, K., Takeuchi, F., Kojima, N., Mizuochi, T., Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J. Biochem. 128 (2000), 621–628.
208. C. Sjöwall, J. Zapf, S. von Löhneysen, 2, I. Magorivska, M. Biermann, C. Janko, S. Winkler, R. Bilyy, G. Schett, M. Herrmann, L.E. Muñoz, Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus, Lupus, (2014) published online.
209. Yarwood, A., Viatte, S., Okada, Y., Plenge, R., Yamamoto, K., Braggss, R., Barton, A., Symmons, D., Raychaudhuri, S., Klareskog, L., Gregersen, P., Worthington, J., Eyre, S., Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study. Ann. Rheumatic Dis. 75 (2016), 317–320.
210. I. Gudelj, P. Salo, I. Trbojevic Akmacic, M. Albers, D. Primorac, M. Perola, G. Lauc, Association of immunoglobulin G glycosylation and incident rheumatoid arthritis during 10 years of follow-up, submitted, (2018).
211. Bond, A., Alavi, A., Axford, J.S., Bourke, B.E., Bruckner, F.E., Kerr, M.A., Maxwell, J.D., Tweed, K.J., Weldon, M.J., Youinou, P., Hay, F.C., A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J. Autoimmun. 10 (1997), 77–85.
212. Wuhrer, M., Stavenhagen, K., Koeleman, C.A., Selman, M.H., Harper, L., Jacobs, B.C., Savage, C.O., Jefferis, R., Deelder, A.M., Morgan, M., Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation. J. Proteome Res. 14 (2015), 1657–1665.
213. Magorivska, I., Munoz, L.E., Janko, C., Dumych, T., Rech, J., Schett, G., Nimmerjahn, F., Bilyy, R., Herrmann, M., Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells. Clin. Exp. Immunol. 184 (2016), 110–117.
214. Sonneveld, M.E., de Haas, M., Koeleman, C., de Haan, N., Zeerleder, S.S., Ligthart, P.C., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation. Sci. Rep., 7, 2017, 8187.
215. Omtvedt, L.A., Royle, L., Husby, G., Sletten, K., Radcliffe, C.M., Harvey, D.J., Dwek, R.A., Rudd, P.M., Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheumatism 54 (2006), 3433–3440.
216. van Timmeren, M.M., van der Veen, B.S., Stegeman, C.A., Petersen, A.H., Hellmark, T., Collin, M., Heeringa, P., IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J. Am. Soc. Nephrol.: JASN 21 (2010), 1103–1114.
217. Nandakumar, K.S., Collin, M., Olsen, A., Nimmerjahn, F., Blom, A.M., Ravetch, J.V., Holmdahl, R., Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur. J. Immunol. 37 (2007), 2973–2982.
218. Albert, H., Collin, M., Dudziak, D., Ravetch, J.V., Nimmerjahn, F., In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 15005–15009.
219. Mihai, S., Albert, H., Ludwig, R.J., Iwata, H., Bjorck, L., Collin, M., Nimmerjahn, F., In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury. Exp. Dermatol. 26 (2017), 691–696.
220. Kapur, R., Della Valle, L., Sonneveld, M., Hipgrave Ederveen, A., Visser, R., Ligthart, P., de Haas, M., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol., 2014.
221. Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C.A., Visser, R., Einarsdottir, H.K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A.M., Blank, D., Skogen, B., Killie, M.K., Michaelsen, T.E., de Haas, M., Rispens, T., van der Schoot, C.E., Wuhrer, M., Vidarsson, G., A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123 (2014), 471–480.
222. Sonneveld, M.E., Natunen, S., Sainio, S., Koeleman, C.A., Holst, S., Dekkers, G., Koelewijn, J., Partanen, J., van der Schoot, C.E., Wuhrer, M., Vidarsson, G., Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. Br. J. Haematol. 174 (2016), 310–320.
223. Sonneveld, M.E., Koelewijn, J., de Haas, M., Admiraal, J., Plomp, R., Koeleman, C.A., Hipgrave Ederveen, A.L., Ligthart, P., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. Br. J. Haematol. 176 (2017), 651–660.
224. Mebius, R.E., Kraal, G., Structure and function of the spleen. Nat. Rev. Immunol. 5 (2005), 606–616.
225. Kapur, R., Della Valle, L., Verhagen, O.J., Hipgrave Ederveen, A., Ligthart, P., de Haas, M., Kumpel, B., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion 55 (2015), 553–562.
226. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C.A., Deelder, A., de Haas, M., Vidarsson, G., Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J. Proteome Res. 8 (2009), 450–456.
227. Ho, C.H., Chien, R.N., Cheng, P.N., Liu, J.H., Liu, C.K., Su, C.S., Wu, I.C., Li, I.C., Tsai, H.W., Wu, S.L., Liu, W.C., Chen, S.H., Chang, T.T., Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy. J. Infect. Dis. 211 (2015), 115–124.
228. Rook, G.A., Onyebujoh, P., Wilkins, E., Ly, H.M., Al Attiyah, R., Bahr, G., Corrah, T., Hernandez, H., Stanford, J.L., A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology 81 (1994), 149–154.
229. Gardinassi, L.G., Dotz, V., Hipgrave Ederveen, A., de Almeida, R.P., Nery Costa, C.H., Costa, D.L., de Jesus, A.R., Mayboroda, O.A., Garcia, G.R., Wuhrer, M., de Miranda Santos, I.K., Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation. mBio, 5, 2014, e01844.
230. O'Regan, N.L., Steinfelder, S., Schwedler, C., Rao, G.B., Srikantam, A., Blanchard, V., Hartmann, S., Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals. Parasite Immunol. 36 (2014), 713–720.
231. Mehta, A.S., Long, R.E., Comunale, M.A., Wang, M., Rodemich, L., Krakover, J., Philip, R., Marrero, J.A., Dwek, R.A., Block, T.M., Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 82 (2008), 1259–1270.
232. Ackerman, M.E., Crispin, M., Yu, X., Baruah, K., Boesch, A.W., Harvey, D.J., Dugast, A.S., Heizen, E.L., Ercan, A., Choi, I., Streeck, H., Nigrovic, P.A., Bailey-Kellogg, C., Scanlan, C., Alter, G., Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 123 (2013), 2183–2192.
233. Vestrheim, A.C., Moen, A., Egge-Jacobsen, W., Reubsaet, L., Halvorsen, T.G., Bratlie, D.B., Paulsen, B.S., Michaelsen, T.E., A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immun. Inflamm. Dis. 2 (2014), 76–91.
234. Wang, T.T., Sewatanon, J., Memoli, M.J., Wrammert, J., Bournazos, S., Bhaumik, S.K., Pinsky, B.A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., Taubenberger, J.K., Ahmed, R., Ravetch, J.V., IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity. Science 355 (2017), 395–398.
235. Nishiura, T., Fujii, S., Kanayama, Y., Nishikawa, A., Tomiyama, Y., Iida, M., Karasuno, T., Nakao, H., Yonezawa, T., Taniguchi, N., et al. Carbohydrate analysis of immunoglobulin G myeloma proteins by lectin and high performance liquid chromatography: role of glycosyltransferases in the structures. Cancer Res. 50 (1990), 5345–5350.
236. Aurer, I., Lauc, G., Dumic, J., Rendic, D., Matisic, D., Milos, M., Heffer-Lauc, M., Flogel, M., Labar, B., Aberrant glycosylation of Igg heavy chain in multiple myeloma. Collegium Antropologicum 31 (2007), 247–251.
237. Fleming, S.C., Smith, S., Knowles, D., Skillen, A., Self, C.H., Increased sialylation of oligosaccharides on IgG paraproteins - a potential new tumour marker in multiple myeloma. J. Clin. Pathol. 51 (1998), 825–830.
238. Kinoshita, N., Ohno, M., Nishiura, T., Fujii, S., Nishikawa, A., Kawakami, Y., Uozumi, N., Taniguchi, N., Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin. Cancer Res. 51 (1991), 5888–5892.
239. Hashimoto, R., Toda, T., Tsutsumi, H., Ohta, M., Mori, M., Abnormal N-glycosylation of the immunoglobulin G kappa chain in a multiple myeloma patient with crystalglobulinemia: case report. Int. J. Hematol. 85 (2007), 203–206.
240. Mizuochi, T., Taniguchi, T., Shimizu, A., Kobata, A., Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J. Immunol. 129 (1982), 2016–2020.
241. Jefferis, R., Lund, J., Mizutani, H., Nakagawa, H., Kawazoe, Y., Arata, Y., Takahashi, N., A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. Biochem. J. 268 (1990), 529–537.
242. Farooq, M., Takahashi, N., Arrol, H., Drayson, M., Jefferis, R., Glycosylation of polyclonal and paraprotein IgG in multiple myeloma. Glycoconjugate J. 14 (1997), 489–492.
243. Mittermayr, S., Le, G.N., Clarke, C., Millan Martin, S., Larkin, A.M., O'Gorman, P., Bones, J., Polyclonal Immunoglobulin G N-Glycosylation in the pathogenesis of plasma cell disorders. J. Proteome Res. 16 (2017), 748–762.
244. Gercel-Taylor, C., Bazzett, L.B., Taylor, D.D., Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer. Gynecol. Oncol. 81 (2001), 71–76.
245. Kanoh, Y., Mashiko, T., Danbara, M., Takayama, Y., Ohtani, S., Imasaki, T., Abe, T., Akahoshi, T., Analysis of the oligosaccharide chain of human serum immunoglobulin g in patients with localized or metastatic cancer. Oncology 66 (2004), 365–370.
246. Kanoh, Y., Mashiko, T., Danbara, M., Takayama, Y., Ohtani, S., Egawa, S., Baba, S., Akahoshi, T., Changes in serum IgG oligosaccharide chains with prostate cancer progression. Anticancer Res. 24 (2004), 3135–3139.
247. Kanoh, Y., Ohara, T., Mashiko, T., Abe, T., Masuda, N., Akahoshi, T., Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression. Anticancer Res. 26 (2006), 4293–4297.
248. Saldova, R., Royle, L., Radcliffe, C.M., Abd Hamid, U.M., Evans, R., Arnold, J.N., Banks, R.E., Hutson, R., Harvey, D.J., Antrobus, R., Petrescu, S.M., Dwek, R.A., Rudd, P.M., Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17 (2007), 1344–1356.
249. Bones, J., Mittermayr, S., O'Donoghue, N., Guttman, A., Rudd, P.M., Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal. Chem. 82 (2010), 10208–10215.
250. Arnold, J.N., Saldova, R., Galligan, M.C., Murphy, T.B., Mimura-Kimura, Y., Telford, J.E., Godwin, A.K., Rudd, P.M., Novel glycan biomarkers for the detection of lung cancer. J. Proteome Res. 10 (2011), 1755–1764.
251. Bones, J., Byrne, J.C., O'Donoghue, N., McManus, C., Scaife, C., Boissin, H., Nastase, A., Rudd, P.M., Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. J. Proteome Res. 10 (2011), 1246–1265.
252. Kodar, K., Stadlmann, J., Klaamas, K., Sergeyev, B., Kurtenkov, O., Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconjugate J. 29 (2012), 57–66.
253. Alley, W.R. Jr., Vasseur, J.A., Goetz, J.A., Svoboda, M., Mann, B.F., Matei, D.E., Menning, N., Hussein, A., Mechref, Y., Novotny, M.V., N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J. Proteome Res. 11 (2012), 2282–2300.
254. Arnold, J.N., Saldova, R., Hamid, U.M., Rudd, P.M., Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8 (2008), 3284–3293.
255. Markiewski, M.M., DeAngelis, R.A., Benencia, F., Ricklin-Lichtsteiner, S.K., Koutoulaki, A., Gerard, C., Coukos, G., Lambris, J.D., Modulation of the antitumor immune response by complement. Nat. Immunol. 9 (2008), 1225–1235.
256. Vuckovic, F., Theodoratou, E., Thaci, K., Timofeeva, M., Vojta, A., Stambuk, J., Pucic-Bakovic, M., Rudd, P.M., Derek, L., Servis, D., Wennerstrom, A., Farrington, S.M., Perola, M., Aulchenko, Y., Dunlop, M.G., Campbell, H., Lauc, G., IgG Glycome in colorectal cancer. Clin. Cancer Res. 22 (2016), 3078–3086.
257. Theodoratou, E., Thaci, K., Agakov, F., Timofeeva, M.N., Stambuk, J., Pucic-Bakovic, M., Vuckovic, F., Orchard, P., Agakova, A., Din, F.V., Brown, E., Rudd, P.M., Farrington, S.M., Dunlop, M.G., Campbell, H., Lauc, G., Glycosylation of plasma IgG in colorectal cancer prognosis. Sci. Rep., 6, 2016, 28098.
258. Li, W., Zhu, Z., Chen, W., Feng, Y., Dimitrov, D.S., Crystallizable fragment glycoengineering for therapeutic antibodies development. Front. Immunol., 8, 2017, 1554.
259. Kellner, C., Otte, A., Cappuzzello, E., Klausz, K., Peipp, M., Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy. Transfus. Med. Hemother.: Offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 44 (2017), 327–336.
260. Selim, M.A., Burchette, J.L., Bowers, E.V., de Ridder, G.G., Mo, L., Pizzo, S.V., Gonzalez-Gronow, M., Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival. Melanoma Res. 21 (2011), 323–334.
261. Kanoh, Y., Ohara, T., Tadano, T., Kanoh, M., Akahoshi, T., Changes to N-linked oligosaccharide chains of human serum immunoglobulin G and matrix metalloproteinase-2 with cancer progression. Anticancer Res. 28 (2008), 715–720.
262. Qian, Y., Wang, Y., Zhang, X., Zhou, L., Zhang, Z., Xu, J., Ruan, Y., Ren, S., Xu, C., Gu, J., Quantitative analysis of serum IgG galactosylation assists differential diagnosis of ovarian cancer. J. Proteome Res. 12 (2013), 4046–4055.
263. Kawaguchi-Sakita, N., Kaneshiro-Nakagawa, K., Kawashima, M., Sugimoto, M., Tokiwa, M., Suzuki, E., Kajihara, S., Fujita, Y., Iwamoto, S., Tanaka, K., Toi, M., Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls. Biochem. Biophys. Res. Commun. 469 (2016), 1140–1145.
264. Knežević A., Gornik, O., Polašek, O., Pučić M., Novokmet, M., Redžić I., Rudd, P.M., Wright, A.F., Campbell, H., Rudan, I., Lauc, G., Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 20 (2010), 959–969.
265. Lauc, G., Essafi, A., Huffman, J.E., Hayward, C., Knezevic, A., Kattla, J.J., Polasek, O., Gornik, O., Vitart, V., Abrahams, J.L., Pucic, M., Novokmet, M., Redzic, I., Campbell, S., Wild, S.H., Borovecki, F., Wang, W., Kolcic, I., Zgaga, L., Gyllensten, U., Wilson, J.F., Wright, A.F., Hastie, N.D., Campbell, H., Rudd, P.M., Rudan, I., Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet., 6, 2010, e1001256.
266. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G., McCulloch, L.J., Ferreira, T., Grallert, H., Amin, N., Wu, G., Willer, C.J., Raychaudhuri, S., McCarroll, S.A., Langenberg, C., Hofmann, O.M., Dupuis, J., Qi, L., Segre, A.V., van Hoek, M., Navarro, P., Ardlie, K., Balkau, B., Benediktsson, R., Bennett, A.J., Blagieva, R., Boerwinkle, E., Bonnycastle, L.L., Bengtsson Bostrom, K., Bravenboer, B., Bumpstead, S., Burtt, N.P., Charpentier, G., Chines, P.S., Cornelis, M., Couper, D.J., Crawford, G., Doney, A.S., Elliott, K.S., Elliott, A.L., Erdos, M.R., Fox, C.S., Franklin, C.S., Ganser, M., Gieger, C., Grarup, N., Green, T., Griffin, S., Groves, C.J., Guiducci, C., Hadjadj, S., Hassanali, N., Herder, C., Isomaa, B., Jackson, A.U., Johnson, P.R., Jorgensen, T., Kao, W.H., Klopp, N., Kong, A., Kraft, P., Kuusisto, J., Lauritzen, T., Li, M., Lieverse, A., Lindgren, C.M., Lyssenko, V., Marre, M., Meitinger, T., Midthjell, K., Morken, M.A., Narisu, N., Nilsson, P., Owen, K.R., Payne, F., Perry, J.R., Petersen, A.K., Platou, C., Proenca, C., Prokopenko, I., Rathmann, W., Rayner, N.W., Robertson, N.R., Rocheleau, G., Roden, M., Sampson, M.J., Saxena, R., Shields, B.M., Shrader, P., Sigurdsson, G., Sparso, T., Strassburger, K., Stringham, H.M., Sun, Q., Swift, A.J., Thorand, B., Tichet, J., Tuomi, T., van Dam, R.M., van Haeften, T.W., van Herpt, T., van Vliet-Ostaptchouk, J.V., Bragi Walters, G., Weedon, M.N., Wijmenga, C., Witteman, J., Bergman, R.N., Cauchi, S., Collins, F.S., Gloyn, A.L., Gyllensten, U., Hansen, T., Hide, W.A., Hitman, G.A., Hofman, A., Hunter, D.J., Hveem, K., Laakso, M., Mohlke, K.L., Morris, A.D., Palmer, C.N., Pramstaller, P.P., Rudan, I., Sijbrands, E., Stein, L.D., Tuomilehto, J., Uitterlinden, A., Walker, M., Wareham, N.J., Watanabe, R.M., Abecasis, G.R., Boehm, B.O., Campbell, H., Daly, M.J., Hattersley, A.T., Hu, F.B., Meigs, J.B., Pankow, J.S., Pedersen, O., Wichmann, H.E., Barroso, I., Florez, J.C., Frayling, T.M., Groop, L., Sladek, R., Thorsteinsdottir, U., Wilson, J.F., Illig, T., Froguel, P., van Duijn, C.M., Stefansson, K., Altshuler, D., Boehnke, M., McCarthy, M.I., Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42 (2010), 579–589.
267. Kooner, J.S., Saleheen, D., Sim, X., Sehmi, J., Zhang, W., Frossard, P., Been, L.F., Chia, K.S., Dimas, A.S., Hassanali, N., Jafar, T., Jowett, J.B., Li, X., Radha, V., Rees, S.D., Takeuchi, F., Young, R., Aung, T., Basit, A., Chidambaram, M., Das, D., Grundberg, E., Hedman, A.K., Hydrie, Z.I., Islam, M., Khor, C.C., Kowlessur, S., Kristensen, M.M., Liju, S., Lim, W.Y., Matthews, D.R., Liu, J., Morris, A.P., Nica, A.C., Pinidiyapathirage, J.M., Prokopenko, I., Rasheed, A., Samuel, M., Shah, N., Shera, A.S., Small, K.S., Suo, C., Wickremasinghe, A.R., Wong, T.Y., Yang, M., Zhang, F., Abecasis, G.R., Barnett, A.H., Caulfield, M., Deloukas, P., Frayling, T.M., Froguel, P., Kato, N., Katulanda, P., Kelly, M.A., Liang, J., Mohan, V., Sanghera, D.K., Scott, J., Seielstad, M., Zimmet, P.Z., Elliott, P., Teo, Y.Y., McCarthy, M.I., Danesh, J., Tai, E.S., Chambers, J.C., Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat. Genet. 43 (2011), 984–989.
268. Hertle, E., Stehouwer, C.D., van Greevenbroek, M.M., The complement system in human cardiometabolic disease. Mol. Immunol. 61 (2014), 135–148.
269. Ghosh, P., Sahoo, R., Vaidya, A., Chorev, M., Halperin, J.A., Role of complement and complement regulatory proteins in the complications of diabetes. Endocrine Rev. 36 (2015), 272–288.
270. Butler, M., Quelhas, D., Critchley, A.J., Carchon, H., Hebestreit, H.F., Hibbert, R.G., Vilarinho, L., Teles, E., Matthijs, G., Schollen, E., Argibay, P., Harvey, D.J., Dwek, R.A., Jaeken, J., Rudd, P.M., Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology 13 (2003), 601–622.
271. Saldova, R., Stockmann, H., O'Flaherty, R., Lefeber, D.J., Jaeken, J., Rudd, P.M., N-Glycosylation of serum IgG and total glycoproteins in MAN1B1 deficiency. J. Proteome Res. 14 (2015), 4402–4412.
272. Coss, K.P., Byrne, J.C., Coman, D.J., Adamczyk, B., Abrahams, J.L., Saldova, R., Brown, A.Y., Walsh, O., Hendroff, U., Carolan, C., Rudd, P.M., Treacy, E.P., IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia. Mol. Genet. Metab. 105 (2012), 212–220.
273. Knerr, I., Coss, K.P., Kratzsch, J., Crushell, E., Clark, A., Doran, P., Shin, Y., Stockmann, H., Rudd, P.M., Treacy, E., Effects of temporary low-dose galactose supplements in children aged 5–12 y with classical galactosemia: a pilot study. Pediatr. Res. 78 (2015), 272–279.
274. Maratha, A., Stockmann, H., Coss, K.P., Estela Rubio-Gozalbo, M., Knerr, I., Fitzgibbon, M., McVeigh, T.P., Foley, P., Moss, C., Colhoun, H.O., van Erven, B., Stephens, K., Doran, P., Rudd, P., Treacy, E., Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis. Eur. J. Hum. Genet.: EJHG 24 (2016), 976–984.
275. Stockmann, H., Coss, K.P., Rubio-Gozalbo, M.E., Knerr, I., Fitzgibbon, M., Maratha, A., Wilson, J., Rudd, P., Treacy, E.P., IgG N-glycosylation galactose incorporation ratios for the monitoring of classical galactosaemia. JIMD Rep. 27 (2016), 47–53.
276. Hernandez-Pando, R., Reyes, P., Espitia, C., Wang, Y., Rook, G., Mancilla, R., Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis. J. Rheumatol. 21 (1994), 1870–1876.
277. Pilkington, C., Yeung, E., Isenberg, D., Lefvert, A.K., Rook, G.A., Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis. Autoimmunity 22 (1995), 107–111.
278. Bond, A., Alavi, A., Axford, J.S., Youinou, P., Hay, F.C., The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin. Exp. Immunol. 105 (1996), 99–103.
279. Sumar, N., Isenberg, D.A., Bodman, K.B., Soltys, A., Young, A., Leak, A.M., Round, J., Hay, F.C., Roitt, I.M., Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor. Ann. Rheumatic Dis. 50 (1991), 607–610.
280. Ercan, A., Barnes, M.G., Hazen, M., Tory, H., Henderson, L., Dedeoglu, F., Fuhlbrigge, R.C., Grom, A., Holm, I.A., Kellogg, M., Kim, S., Adamczyk, B., Rudd, P.M., Son, M.B., Sundel, R.P., Foell, D., Glass, D.N., Thompson, S.D., Nigrovic, P.A., Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheumatism 64 (2012), 3025–3033.
281. Cheng, H.D., Stockmann, H., Adamczyk, B., McManus, C.A., Ercan, A., Holm, I.A., Rudd, P.M., Ackerman, M.E., Nigrovic, P.A., High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis. Glycobiology 27 (2017), 1099–1108.
282. Miyoshi, E., Shinzaki, S., Fujii, H., Iijima, H., Kamada, Y., Takehara, T., Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease. Proteomics Clin. Appl. 10 (2016), 384–390.
283. Simurina, M., de Haan, N., Vuckovic, F., Kennedy, N.A., Stambuk, J., Falck, D., Trbojevic-Akmacic, I., Clerc, F., Razdorov, G., Khon, A., Latiano, A., D'Inca, R., Danese, S., Targan, S., Landers, C., Dubinsky, M., C. Inflammatory Bowel Disease Biomarkers, McGovern, D.P.B., Annese, V., Wuhrer, M., Lauc, G., Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases. Gastroenterology 154 (2018), 1320–1333 e1310.
284. Pilkington, C., Taylor, P.V., Silverman, E., Isenberg, D.A., Costello, A.M., Rook, G.A., Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus. Rheumatol. Int. 16 (1996), 89–94.
285. Leirisalo-Repo, M., Hernandez-Munoz, H.E., Rook, G.A., Agalactosyl IgG is elevated in patients with active spondyloarthropathy. Rheumatol. Int. 18 (1999), 171–176.
286. Holland, M., Takada, K., Okumoto, T., Takahashi, N., Kato, K., Adu, D., Ben-Smith, A., Harper, L., Savage, C.O., Jefferis, R., Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin. Exp. Immunol. 129 (2002), 183–190.
287. Cremata, J.A., Sorell, L., Montesino, R., Garcia, R., Mata, M., Cabrera, G., Galvan, J.A., Garcia, G., Valdes, R., Garrote, J.A., Hypogalactosylation of serum IgG in patients with coeliac disease. Clin. Exp. Immunol. 133 (2003), 422–429.
288. Selman, M.H., Niks, E.H., Titulaer, M.J., Verschuuren, J.J., Wuhrer, M., Deelder, A.M., IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J. Proteome Res. 10 (2011), 143–152.
289. Perdivara, I., Peddada, S.D., Miller, F.W., Tomer, K.B., Deterding, L.J., Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes. J. Proteome Res. 10 (2011), 2969–2978.
290. Fokkink, W.J., Selman, M.H., Wuhrer, M., Jacobs, B.C., Immunoglobulin G Fc N-glycosylation in Guillain-Barre syndrome treated with intravenous immunoglobulin. Clin. Exp. Immunol. 178:Suppl 1 (2014), 105–107.
291. Bermingham, M.L., Colombo, M., McGurnaghan, S.J., Blackbourn, L.A.K., Vuckovic, F., Pucic Bakovic, M., Trbojevic-Akmacic, I., Lauc, G., Agakov, F., Agakova, A.S., Hayward, C., Klaric, L., Palmer, C.N.A., Petrie, J.R., Chalmers, J., Collier, A., Green, F., Lindsay, R.S., Macrury, S., McKnight, J.A., Patrick, A.W., Thekkepat, S., Gornik, O., McKeigue, P.M., Colhoun, H.M., S.T.B, Investigators, N-glycan profile and kidney disease in type 1 diabetes. Diabetes Care, 2017.
292. Ruhaak, L.R., Kim, K., Stroble, C., Taylor, S.L., Hong, Q., Miyamoto, S., Lebrilla, C.B., Leiserowitz, G., Protein-specific differential glycosylation of immunoglobulins in serum of ovarian cancer patients. J. Proteome Res. 15 (2016), 1002–1010.
293. Kanoh, Y., Egawa, S., Baba, S., Akahoshi, T., Associations of IgG N-linked oligosaccharide chains and proteases in sera of prostate cancer patients with and without alpha2-macroglobulin deficiency. J. Clin. Lab. Anal. 23 (2009), 125–131.
294. Kazuno, S., Furukawa, J., Shinohara, Y., Murayama, K., Fujime, M., Ueno, T., Fujimura, T., Glycosylation status of serum immunoglobulin G in patients with prostate diseases. Cancer Med. 5 (2016), 1137–1146.
295. Chen, G., Wang, Y., Qin, X., Li, H., Guo, Y., Wang, Y., Liu, H., Wang, X., Song, G., Li, F., Li, F., Guo, S., Qiu, L., Li, Z., Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential. Electrophoresis 34 (2013), 2407–2416.
296. Filley, E., Andreoli, A., Steele, J., Waters, M., Wagner, D., Nelson, D., Tung, K., Rademacher, T., Dwek, R., Rook, G.A., A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum. Clin. Exp. Immunol. 76 (1989), 343–347.
297. Rademacher, T.W., Parekh, R.B., Dwek, R.A., Isenberg, D., Rook, G., Axford, J.S., Roitt, I., The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol. 10 (1988), 231–249.
298. Pilkington, C., Basaran, M., Barlan, I., Costello, A.M., Rook, G.A., Raised levels of agalactosyl IgG in childhood tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 90 (1996), 167–168.
299. Moore, J.S., Wu, X., Kulhavy, R., Tomana, M., Novak, J., Moldoveanu, Z., Brown, R., Goepfert, P.A., Mestecky, J., Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. Aids 19 (2005), 381–389.
300. Nakao, H., Nishikawa, A., Nishiura, T., Kanayama, Y., Tarui, S., Taniguchi, N., Hypogalactosylation of immunoglobulin G sugar chains and elevated serum interleukin 6 in Castleman's disease. Clin. Chim. Acta; Int. J. Clin. Chem. 197 (1991), 221–228.
301. Coman, D.J., Murray, D.W., Byrne, J.C., Rudd, P.M., Bagaglia, P.M., Doran, P.D., Treacy, E.P., Galactosemia, a single gene disorder with epigenetic consequences. Pediatric Res. 67 (2010), 286–292.
302. Coss, K.P., Hawkes, C.P., Adamczyk, B., Stockmann, H., Crushell, E., Saldova, R., Knerr, I., Rubio-Gozalbo, M.E., Monavari, A.A., Rudd, P.M., Treacy, E.P., N-glycan abnormalities in children with galactosemia. J. Proteome Res. 13 (2014), 385–394.
303. Lundstrom, S.L., Yang, H., Lyutvinskiy, Y., Rutishauser, D., Herukka, S.K., Soininen, H., Zubarev, R.A., Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment. J. Alzheimer's Dis.: JAD 38 (2014), 567–579.
304. Chen, G., Wang, Y., Qiu, L., Qin, X., Liu, H., Wang, X., Wang, Y., Song, G., Li, F., Guo, Y., Li, F., Guo, S., Li, Z., Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer. J. Proteomics 75 (2012), 2824–2834.
305. Russell, A.C., Simurina, M., Garcia, M.T., Novokmet, M., Wang, Y., Rudan, I., Campbell, H., Lauc, G., Thomas, M.G., Wang, W., The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease. Glycobiology 27 (2017), 501–510.
306. Chen, X.X., Chen, Y.Q., Ye, S., Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus. Lupus 24 (2015), 948–954.
307. Fickentscher, C., Magorivska, I., Janko, C., Biermann, M., Bilyy, R., Nalli, C., Tincani, A., Medeghini, V., Meini, A., Nimmerjahn, F., Schett, G., Munoz, L.E., Andreoli, L., Herrmann, M., The pathogenicity of Anti-beta2GP1-IgG autoantibodies depends on Fc glycosylation. J. Immunol. Res., 2015, 2015, 638129.
308. Vadrevu, S.K., Trbojevic-Akmacic, I., Kossenkov, A.V., Colomb, F., Giron, L.B., Anzurez, A., Lynn, K., Mounzer, K., Landay, A.L., Kaplan, R.C., Papasavvas, E., Montaner, L.J., Lauc, G., Abdel-Mohsen, M., Frontline Science: plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy. J. Leukocyte Biol., 2018.
309. Ruhaak, L.R., Nguyen, U.T., Stroble, C., Taylor, S.L., Taguchi, A., Hanash, S.M., Lebrilla, C.B., Kim, K., Miyamoto, S., Enrichment strategies in glycomics-based lung cancer biomarker development. Proteomics Clin. Appl. 7 (2013), 664–676.
310. Freidin, M.B., Keser, T., Gudelj, I., Stambuk, J., Vucenovic, D., Allegri, M., Pavic, T., Simurina, M., Fabiane, S.M., Lauc, G., Williams, F.M., The association between low back pain and composition of IgG glycome. Sci. Rep., 6, 2016, 26815.
311. Gornik, I., Maravić G., Dumić J., Flögel, M., Lauc, G., Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin. Biochem. 32 (1999), 605–608.
312. Comunale, M.A., Lowman, M., Long, R.E., Krakover, J., Philip, R., Seeholzer, S., Evans, A.A., Hann, H.W., Block, T.M., Mehta, A.S., Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 5 (2006), 308–315.
313. T.C.f.f. glycomics., Symbol and Text Nomenclature for Representation of Glycan Structure, Functional Genomics Gateway.